Author:
Morris Elana,Teplinskaya Anna,Olansky Evelyn,Rinderle Jeffrey Kemp,Chapin-Bardales Johanna,Barak Narquis,Brady Kathleen A.,Braunstein Sarah,Davis Jasmine,Glick Sara,Harrington Andrea,Lopez Jasmine,Ma Yingbo,Martin Aleks,Mustaafaa Genetha,Nassau Tanner,Olaes Gia,Reuer Jennifer,Rivera Alexis,Robinson William T.,Sey Ekow Kwa,Sicro Sofia,Taylor Brittany,Trujillo Dillon,Wilson Erin,Wortley Pascale, ,
Publisher
Centers for Disease Control MMWR Office
Reference36 articles.
1. CDC. US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update: a clinical practice guideline. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf
2. Ending the HIV epidemic.;Fauci;JAMA,2019
3. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.;Grant;N Engl J Med,2010
4. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.;Grohskopf;J Acquir Immune Defic Syndr,2013
5. Prevention-effective adherence trajectories among transgender women indicated for PrEP in the United States: a prospective cohort study.;Cooney;Ann Epidemiol,2022